Cachexia as a major public health problem: frequent, costly, and deadly

被引:125
作者
Farkas, Jerneja [1 ]
von Haehling, Stephan [2 ]
Kalantar-Zadeh, Kamyar [3 ]
Morley, John E. [4 ]
Anker, Stefan D. [2 ,5 ]
Lainscak, Mitja [2 ,6 ]
机构
[1] Univ Ljubljana, Fac Med, Dept Publ Hlth, Ljubljana, Slovenia
[2] Charite Campus Virchow Klinikum, Div Cardiol, Appl Cachexia Res, Berlin, Germany
[3] Univ Calif Irvine, Sch Med, Div Nephrol & Hypertens, UC Irvine Med Ctr, Orange, CA USA
[4] St Louis Univ, Med Ctr, Div Geriatr Med, St Louis, MO USA
[5] IRCCS San Raffaele, Ctr Clin & Basic Res, Rome, Italy
[6] Univ Clin Resp & Allerg Dis Golnik, Div Cardiol, Golnik, Slovenia
关键词
Cachexia; Chronic disease; Prevention; Public health; NONCOMMUNICABLE DISEASES; HEART-DISEASE; RISK-FACTORS; OBESITY; CHALLENGES; PREVENTION; FAILURE; PARADOX; AFRICA; CANCER;
D O I
10.1007/s13539-013-0105-y
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
030301 [社会学]; 100201 [内科学];
摘要
Perception of healthy body size and composition differs considerably across the globe, ethnic groups, cultures, and even inside medical community. Although the concept of ideal body weight has evolved over the past decades, the observation that weight loss can have more deleterious effects within a short-term period than weight gain has remained rather consistent. Weight loss, as a prelude to cachexia, occurs frequently in a variety of disease states and meets the requirements of a global public health problem. Consequently, interventions to prevent and control chronic diseases require a comprehensive approach that targets a population as a whole and includes both prevention and treatment strategies. Around the globe, cachexia awareness campaigns and expanding the current public health priorities to highlight the cachexia magnitude and areas of interventions is necessary. Simultaneously, scientific efforts should provide us with more reliable estimates of body wasting and cachexia as well as pathophysiology of cachexia-associated death. As certain proportion of patients will, irrespective of preventive measures, eventually develop cachexia, a quest for effective remedy remains vital.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 38 条
[1]
[Anonymous], 2009, 2008 2013 ACTION PLA
[2]
[Anonymous], 2007, ETHICS PREVENTION PU
[3]
[Anonymous], OXFORD TXB PUBLIC HL
[4]
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design [J].
Coats, Andrew J. Stewart ;
Srinivasan, Venkatesan ;
Surendran, Jayaraman ;
Chiramana, Haritha ;
Vangipuram, Shankar R. K. G. ;
Bhatt, Nirajkumar N. ;
Jain, Minish ;
Shah, Sandip ;
Ali, Irfhan A. B. H. ;
Fuang, Ho G. ;
Hassan, Mohammed Z. M. ;
Beadle, John ;
Tilson, Julia ;
Kirwan, Bridget-Anne ;
Anker, Stefan D. .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2011, 2 (04) :201-207
[5]
Cachexia: A new definition [J].
Evans, William J. ;
Morley, John E. ;
Argiles, Josep ;
Bales, Connie ;
Baracos, Vickie ;
Guttridge, Denis ;
Jatoi, Aminah ;
Kalantar-Zadeh, Kamyar ;
Lochs, Herbert ;
Mantovani, Giovanni ;
Marks, Daniel ;
Mitch, William E. ;
Muscaritoli, Maurizio ;
Najand, Armine ;
Ponikowski, Piotr ;
Rossi Fanelli, Filippo ;
Schambelan, Morrie ;
Schols, Annemie ;
Schuster, Michael ;
Thomas, David ;
Wolfe, Robert ;
Anker, Stefan D. ;
Boyce, Amanda ;
Nuckolls, Glen .
CLINICAL NUTRITION, 2008, 27 (06) :793-799
[6]
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants [J].
Finucane, Mariel M. ;
Stevens, Gretchen A. ;
Cowan, Melanie J. ;
Danaei, Goodarz ;
Lin, John K. ;
Paciorek, Christopher J. ;
Singh, Gitanjali M. ;
Gutierrez, Hialy R. ;
Lu, Yuan ;
Bahalim, Adil N. ;
Farzadfar, Farshad ;
Riley, Leanne M. ;
Ezzati, Majid .
LANCET, 2011, 377 (9765) :557-567
[7]
Epidemiology and causation of coronary heart disease and stroke in India [J].
Gupta, R. ;
Joshi, P. ;
Mohan, V. ;
Reddy, K. S. ;
Yusuf, S. .
HEART, 2008, 94 (01) :16-26
[8]
Chagas Cardiomyopathy in the Context of the Chronic Disease Transition [J].
Hidron, Alicia I. ;
Gilman, Robert H. ;
Justiniano, Juan ;
Blackstock, Anna J. ;
LaFuente, Carlos ;
Selum, Walter ;
Calderon, Martiza ;
Verastegui, Manuela ;
Ferrufino, Lisbeth ;
Valencia, Eduardo ;
Tornheim, Jeffrey A. ;
O'Neal, Seth ;
Comer, Robert ;
Galdos-Cardenas, Gerson ;
Bern, Caryn .
PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (05)
[9]
Hypertension in developing countries [J].
Ibrahim, M. Mohsen ;
Damasceno, Albertino .
LANCET, 2012, 380 (9841) :611-619
[10]
Risk factor paradox in wasting diseases [J].
Kalantar-Zadeh, Kamyar ;
Horwich, Tamara B. ;
Oreopoulos, Antigone ;
Kovesdy, Csaba P. ;
Younessi, Houman ;
Anker, Stefan D. ;
Morley, John E. .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2007, 10 (04) :433-442